Humacyte, Inc.
HUMA
$3.13
$0.123.99%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -39.20M | -56.66M | -31.90M | -25.11M | -26.00M |
| Total Depreciation and Amortization | 1.81M | 1.78M | 1.79M | 1.83M | 1.83M |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 11.07M | 29.54M | 7.42M | 1.09M | 4.11M |
| Change in Net Operating Assets | 3.41M | 4.06M | -4.66M | 3.13M | 7.05M |
| Cash from Operations | -22.91M | -21.29M | -27.35M | -19.05M | -13.01M |
| Capital Expenditure | -934.00K | -184.00K | -391.00K | -150.00K | -493.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Investing | -934.00K | -184.00K | -391.00K | -150.00K | -493.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -659.00K | -644.00K | -603.00K | -588.00K | -577.00K |
| Issuance of Common Stock | 495.00K | 787.00K | 43.40M | 253.00K | 99.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.01M | -610.00K | 20.00M | 0.00 | -286.00K |
| Cash from Financing | 849.00K | -467.00K | 62.80M | -335.00K | -764.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.99M | -21.94M | 35.06M | -19.54M | -14.26M |
